{"id":1374,"date":"2024-09-25T11:08:03","date_gmt":"2024-09-25T11:08:03","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/"},"modified":"2025-12-25T19:00:48","modified_gmt":"2025-12-25T18:00:48","slug":"transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/","title":{"rendered":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma"},"content":{"rendered":"<p><span style=\"font-size: 18pt;color: #000000;background-color: #ffffff;font-family: helvetica\"><strong>Transdisciplinary Immunology Journal Club #TIJC<\/strong><\/span><\/p>\n<p><span style=\"font-family: helvetica\"><strong><span style=\"font-size: 14pt;background-color: #000000;color: #ffff00\">JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma<\/span><br \/><\/strong>Pr\u00e9sent\u00e9 par : <strong>Dr. Samuel Bitoun<br \/><\/strong>D\u00e9partement de rhumatologie H\u00f4pital Bic\u00eatre AP-HP, Universit\u00e9 Paris-Saclay, Inserm UMR1184, FHU CARE<\/span><br \/><span style=\"font-family: helvetica\">Date : <strong>Jeudi 7 novembre 2024<br \/><\/strong>Heure : <strong>17h00 \u2013 18h00<br \/><a href=\"https:\/\/youtu.be\/1k7rr2e4HxQ?si=rfk5Vm8aY4OLnY9f&amp;t=1\">Replay TIJC#1 : JAK Inhibitors and Cancer: Friend or Foe? par le Dr Samuel Bitoun, disponible ICI<\/a><br \/><\/strong><br \/><\/span><\/p>\n<p><span style=\"font-family: helvetica\">Venez explorer les nouvelles fronti\u00e8res de l&rsquo;immunologie \u00e0 travers la transdisciplinarit\u00e9 !<\/span><br \/><span style=\"font-family: helvetica\"><strong>Plus d\u2019info&nbsp;: <a href=\"en\/news-and-events\/bibliocare-l-alliance-des-connaissances-pour-reinventer-l-immunologie\">ici<\/a> <\/strong><\/span><\/p>\n<p><span style=\"color: #000000;font-family: helvetica\"><strong>Scientific Committee (non-exhaustive list):<\/strong><\/span><br \/><span style=\"color: #000000;font-family: helvetica\">Samuel Bitoun, Xavier Mariette,&nbsp; Fran\u00e7ois-Xavier Danlos, Camille Bigenwald, Beno\u00eet Kloeckner, Marie Naigeon, Matthieu Roulleaux Dugage, Ronan Flippot, Judith Michels, Marine Fidelle, Rami Bechara, etc.<\/span><\/p>\n<p><span style=\"font-family: helvetica\"><span style=\"font-size: 14pt\"><span style=\"color: #000000\"><strong>Explore new immunology frontiers through transdisciplinarity!&nbsp;<\/strong><\/span><\/span><span style=\"font-size: 14pt\"><span style=\"color: #000000\"><strong>Come explore the new frontiers of immunology together through transdisciplinarity!<\/strong><\/span><\/span><\/span><\/p>\n<p><span style=\"font-family: helvetica\"><strong>Lancement de la premi\u00e8re biblio du Transdisciplinary Immunology Journal Club&nbsp;! <\/strong>Nous avons le plaisir de vous inviter au lancement officiel du <strong>Transdisciplinary Immunology Journal Club<\/strong> (#TIJC), une initiative unique destin\u00e9e aux m\u00e9decins, chercheurs et \u00e9tudiants. Ce club a pour objectif de cr\u00e9er un espace d\u2019\u00e9changes transdisciplinaires autour des derni\u00e8res avanc\u00e9es en immunopathologie, avec une approche partag\u00e9e entre diverses sp\u00e9cialit\u00e9s m\u00e9dicales. C&rsquo;est une occasion rare de confronter diff\u00e9rentes perspectives pour am\u00e9liorer la prise en charge des patients.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Transdisciplinary Immunology Journal Club #TIJC JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaPr\u00e9sent\u00e9 par : Dr. Samuel BitounD\u00e9partement de rhumatologie H\u00f4pital Bic\u00eatre AP-HP, Universit\u00e9 Paris-Saclay, Inserm UMR1184, FHU CAREDate : Jeudi 7 novembre 2024Heure : 17h00 \u2013 18h00Replay TIJC#1 : JAK Inhibitors and Cancer: Friend or Foe? par le Dr Samuel Bitoun, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"event_date":"Thursday, November 7, 2024","event_location":"Webinaire","event_time":"5 PM - 6 PM","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1374","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=1374"}],"version-history":[{"count":2,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1374\/revisions"}],"predecessor-version":[{"id":2392,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1374\/revisions\/2392"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/1375"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=1374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=1374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=1374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}